Wen-E Wei
Overview
Explore the profile of Wen-E Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhong J, Xiang X, Wang Y, Liu X, Qi L, Luo C, et al.
J Cell Physiol
. 2019 Jul;
235(2):1090-1102.
PMID: 31256427
Long noncoding RNAs (lncRNAs) regulate tumor development and progression by promoting proliferation, invasion, and metastasis. The oncogenic role of lncRNA SNHG16 in hepatocellular carcinoma (HCC) has not been revealed. LncRNA...
2.
Wei W, Mao N, Ning S, Li J, Liu H, Xie T, et al.
PLoS One
. 2016 Dec;
11(12):e0168795.
PMID: 27992557
An association between epidermal growth factor receptor (EGFR) and clinical characteristics of non-small cell lung cancer (NSCLC) was reported ten years ago. In addition, a different type of relationship was...
3.
Yan L, Chen Z, Li L, Chen J, Mo X, Qin Y, et al.
Tumour Biol
. 2016 Oct;
37:15925–15936.
PMID: 27704360
Activation of the transcription factor E2F-1 gene is a negative event in dendritic cell (DC) maturation process. Down-regulation of E2F1 causes immaturity of DC thereby stopping antigen production which in...
4.
Yan L, Chen Z, Li-Li , Chen J, Wei W, Mo X, et al.
Oncotarget
. 2016 Sep;
7(43):70699-70714.
PMID: 27683111
Resistance to oxaliplatin (OXA)-based chemotherapy regimens continues to be a major cause of gastric cancer (GC) recurrence and metastasis. We analyzed GC samples and matched non-tumorous control stomach tissues from...
5.
Ning S, Li J, Luo C, Wei C, Lu Y, Liu H, et al.
Int J Clin Exp Pathol
. 2015 Feb;
7(12):8740-7.
PMID: 25674240
The overexpressed HER2 (human epidermal growth factor receptor 2) is a valuable therapeutic target. Precise assessment of HER2 status is thus crucial in the treatment of breast cancer. In this...